References
- Alda, M. (2013). Personalized psychiatry: many questions, fewer answers. Journal of Psychiatry & Neuroscience, 38, 363–365. doi:10.1503/jpn.130221
- de Leon, J. (2009). The future (or lack of future) of personalized prescription in psychiatry. Pharmacological Research, 59, 81–89. doi:10.1016/j.phrs.2008.10.002
- Evers, K. (2009). Personalized medicine in psychiatry: Ethical challenges and opportunities. Dialogues in Clinical Neuroscience, 11, 427–434.
- Fernandes, B. S., Williams, L. M., Steiner, J., Leboyer, M., Carvalho, A. F., & Berk, M. (2017). The new field of ‘precision psychiatry’. BMC Medicine, 15, 80. doi:10.1186/s12916-017-0849-x
- Fountoulakis, K. N., Grunze, H., Vieta, E., Young, A., Yatham, L., Blier, P., … Moeller, H. J. (2016a). The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for Bipolar disorder in adults (CINP-BD-2017), part 3: The clinical guidelines. International Journal of Neuropsychopharmacology, 20, 180–195. doi:10.1093/ijnp/pyw109
- Fountoulakis, K. N., Vieta, E., Young, A., Yatham, L., Grunze, H., Blier, P., … Kasper, S. (2016b). The International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 4: Unmet needs in the treatment of bipolar disorder and recommendations for future research. International Journal of Neuropsychopharmacology, 20, 196–205. doi:10.1093/ijnp/pyw072
- Fountoulakis, K. N., Yatham, L., Grunze, H., Vieta, E., Young, A., Blier, P., … Moeller, H. J. (2016c). The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, grading of the evidence, and a precise algorithm. International Journal of Neuropsychopharmacology, 20, 98–120. doi:10.1093/ijnp/pyw100
- Fountoulakis, K. N., Young, A., Yatham, L., Grunze, H., Vieta, E., Blier, P., … Kasper, S. (2016d). The International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 1: Background and methods of the development of guidelines. International Journal of Neuropsychopharmacology, 20, 121–179. doi:10.1093/ijnp/pyw091
- Gandal, M. J., Leppa, V., Won, H., Parikshak, N. N., & Geschwind, D. H. (2016). The road to precision psychiatry: Translating genetics into disease mechanisms. Nature Neuroscience, 19, 1397–1407. doi:10.1038/nn.4409
- Gurwitz, D., & Weizman, A. (2004). Personalized psychiatry: A realistic goal. Pharmacogenomics, 5, 213–217. doi:10.1517/phgs.5.2.213.27487
- Insel, T. R. (2014). The NIMH Research Domain Criteria (RDoC) Project: Precision medicine for psychiatry. American Journal of Psychiatry, 171, 395–397. doi:10.1176/appi.ajp.2014.14020138
- Moller, H. J., & Rujescu, D. (2010). Pharmacogenetics–genomics and personalized psychiatry. European Psychiatry: The Journal of the Association of European Psychiatrists, 25, 291–293. doi:10.1016/j.eurpsy.2009.12.015
- Ozomaro, U., Wahlestedt, C., & Nemeroff, C. B. (2013). Personalized medicine in psychiatry: Problems and promises. BMC Medicine, 11, 132. doi:10.1186/1741-7015-11-132
- Terry, S. F. (2015). Obama's precision medicine initiative. Genetic Testing and Molecular Biomarkers, 19, 113–114. doi:10.1089/gtmb.2015.1563
- van Os, J., Delespaul, P., Wigman, J., Myin-Germeys, I., & Wichers, M. (2013). Beyond DSM and ICD: Introducing “precision diagnosis” for psychiatry using momentary assessment technology. World Psychiatry, 12, 113–117. doi:10.1002/wps.20046